John W. Baddley
Expertise in
14
conditions

Dr. John W. Baddley

Infectious Disease
1717 East Monument Street, Park Building, Ground Level, Park Building, Ground Level, 
Baltimore, MD 
Clinical Trials:Currently Recruiting for 1 Trial
27 Years of Experience
Expertise in
14
conditions
1717 East Monument Street, Park Building, Ground Level, Park Building, Ground Level, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Baddley is an Infectious Disease provider in Baltimore, Maryland. Dr. Baddley has been practicing medicine for over 27 years is highly rated in 14 conditions, according to our data. His top areas of expertise are Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia.

His clinical research consists of co-authoring 179 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Alabama School Of Medicine, PUBLIC HEALTH, MSPH, 2008
Residency
Louisiana State University School of Medicine in New Orleans, Internal Medicine, 1998
Specialties
Infectious Disease
Licenses
Internal Medicine in AL
Board Certifications
American Board Of Internal Medicine
Fellowships
University of Alabama School of Medicine, Infectious Disease (Internal Medicine), 2001
Hospital Affiliations
The Johns Hopkins Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

The Johns Hopkins Hospital
1717 East Monument Street, Park Building, Ground Level, Park Building, Ground Level, Baltimore, MD 21287
Other Locations
Sidney Kimmel Comprehensive Cancer Center
401 North Broadway Street, Weinberg BLDG, Baltimore, MD 21287

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
Enrollment Status: Recruiting
Publish Date: November 20, 2024
Intervention Type: Drug
Study Drug: DAS181
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Multi-Center, Randomized, Open-Label, Comparative Study to Assess the Safety and Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Adult Patients With Blood Stream Infections Due to Staphylococci
A Multi-Center, Randomized, Open-Label, Comparative Study to Assess the Safety and Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Adult Patients With Blood Stream Infections Due to Staphylococci
Enrollment Status: Completed
Publish Date: January 05, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

178 Total Publications

Non-Aspergillus molds.
Non-Aspergillus molds.
Journal: JHLT open
Published: December 01, 2025
Similar Doctors
Expertise in
11
conditions
Dr. Anna P. Durbin
Infectious Disease
Expertise in
11
conditions
Dr. Anna P. Durbin
Infectious Disease

The Johns Hopkins Hospital

1800 Orleans Street, 
Baltimore, MD 
 (0.1 miles away)
410-955-5000
Languages Spoken:
English
See accepted insurances

Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is highly rated in 11 conditions, according to our data. Her top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever.

Expertise in
12
conditions
Dr. Mark Tenforde
Infectious Disease
Expertise in
12
conditions
Dr. Mark Tenforde
Infectious Disease

Johns Hopkins Hospital

600 N Wolfe St, 
Baltimore, MD 
 (0.1 miles away)
206-940-6927
Languages Spoken:
English

Mark Tenforde is a primary care provider, practicing in Infectious Disease in Baltimore, Maryland. Dr. Tenforde is highly rated in 12 conditions, according to our data. His top areas of expertise are Meningitis, Cryptococcal Meningitis, Cryptococcosis, and Flu.

Kathleen Neuzil
Expertise in
9
conditions
Dr. Kathleen Neuzil
Infectious Disease
Expertise in
9
conditions
Dr. Kathleen Neuzil
Infectious Disease

Office

685 W Baltimore St Rm 480, 
Baltimore, MD 
 (1.6 miles away)
410-706-6554
Languages Spoken:
English

Kathleen Neuzil is an Infectious Disease provider in Baltimore, Maryland. Dr. Neuzil is highly rated in 9 conditions, according to our data. Her top areas of expertise are Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Baddley's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 26 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile